LLT-1 monoclonal antibodies

N/A

Report date: 2025/03/20 15:41:34

Base Information

Drug NameLLT-1 monoclonal antibodies
Drug Alias NameLectin-like transcript-1 monoclonal antibody
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-Type Lectin Domain Family 2 Member D inhibitors
TargetsC-Type Lectin Domain Family 2 Member D
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZumutor Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZumutor Biologics Inc
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A